vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and MID PENN BANCORP INC (MPB). Click either name above to swap in a different company.
MID PENN BANCORP INC is the larger business by last-quarter revenue ($62.0M vs $31.1M, roughly 2.0× LIFECORE BIOMEDICAL, INC. \DE\). MID PENN BANCORP INC runs the higher net margin — 31.4% vs -32.1%, a 63.5% gap on every dollar of revenue. On growth, MID PENN BANCORP INC posted the faster year-over-year revenue change (30.8% vs -4.5%). MID PENN BANCORP INC produced more free cash flow last quarter ($71.8M vs $25.0K). Over the past eight quarters, MID PENN BANCORP INC's revenue compounded faster (21.1% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Commerce Bancorp was a Cherry Hill, New Jersey–based bank created in 1973. In 2007, it was purchased by Toronto-Dominion Bank, which merged Commerce into TD Banknorth, the latter of which was rebranded to TD Bank.
LFCR vs MPB — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $62.0M |
| Net Profit | $-10.0M | $19.4M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | 43.6% |
| Net Margin | -32.1% | 31.4% |
| Revenue YoY | -4.5% | 30.8% |
| Net Profit YoY | -52.0% | 47.0% |
| EPS (diluted) | $-0.29 | $0.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $62.0M | ||
| Q3 25 | $31.1M | $61.8M | ||
| Q2 25 | — | $54.3M | ||
| Q1 25 | $35.2M | $47.7M | ||
| Q4 24 | $32.6M | $47.4M | ||
| Q3 24 | $24.7M | $45.3M | ||
| Q2 24 | — | $44.1M | ||
| Q1 24 | $35.7M | $42.3M |
| Q4 25 | — | $19.4M | ||
| Q3 25 | $-10.0M | $18.3M | ||
| Q2 25 | — | $4.8M | ||
| Q1 25 | $-14.8M | $13.7M | ||
| Q4 24 | $-6.6M | $13.2M | ||
| Q3 24 | $-16.2M | $12.3M | ||
| Q2 24 | — | $11.8M | ||
| Q1 24 | $15.6M | $12.1M |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | 43.6% | ||
| Q3 25 | -9.9% | 39.3% | ||
| Q2 25 | — | 7.9% | ||
| Q1 25 | -25.7% | 35.2% | ||
| Q4 24 | -6.0% | 34.1% | ||
| Q3 24 | -46.9% | 32.8% | ||
| Q2 24 | — | 32.4% | ||
| Q1 24 | -2.5% | 34.8% |
| Q4 25 | — | 31.4% | ||
| Q3 25 | -32.1% | 29.6% | ||
| Q2 25 | — | 8.8% | ||
| Q1 25 | -42.0% | 28.8% | ||
| Q4 24 | -20.2% | 27.9% | ||
| Q3 24 | -65.7% | 27.1% | ||
| Q2 24 | — | 26.7% | ||
| Q1 24 | 43.8% | 28.7% |
| Q4 25 | — | $0.83 | ||
| Q3 25 | $-0.29 | $0.79 | ||
| Q2 25 | — | $0.22 | ||
| Q1 25 | $-0.47 | $0.71 | ||
| Q4 24 | $-0.25 | $0.72 | ||
| Q3 24 | $-0.53 | $0.74 | ||
| Q2 24 | — | $0.71 | ||
| Q1 24 | $0.42 | $0.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | — |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $814.1M |
| Total Assets | $235.2M | $6.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $18.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $9.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $814.1M | ||
| Q3 25 | $-10.5M | $796.3M | ||
| Q2 25 | — | $775.7M | ||
| Q1 25 | $2.2M | $667.9M | ||
| Q4 24 | $15.4M | $655.0M | ||
| Q3 24 | $-3.9M | $573.1M | ||
| Q2 24 | — | $559.7M | ||
| Q1 24 | $17.7M | $551.0M |
| Q4 25 | — | $6.1B | ||
| Q3 25 | $235.2M | $6.3B | ||
| Q2 25 | — | $6.4B | ||
| Q1 25 | $237.7M | $5.5B | ||
| Q4 24 | $255.4M | $5.5B | ||
| Q3 24 | $246.8M | $5.5B | ||
| Q2 24 | — | $5.4B | ||
| Q1 24 | $246.2M | $5.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $80.0M |
| Free Cash FlowOCF − Capex | $25.0K | $71.8M |
| FCF MarginFCF / Revenue | 0.1% | 115.8% |
| Capex IntensityCapex / Revenue | 5.6% | 13.3% |
| Cash ConversionOCF / Net Profit | — | 4.12× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $132.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $80.0M | ||
| Q3 25 | $1.8M | $26.3M | ||
| Q2 25 | — | $29.0M | ||
| Q1 25 | $1.2M | $11.5M | ||
| Q4 24 | $-6.1M | $51.4M | ||
| Q3 24 | $-613.0K | $16.9M | ||
| Q2 24 | — | $18.0M | ||
| Q1 24 | $-1.4M | $12.4M |
| Q4 25 | — | $71.8M | ||
| Q3 25 | $25.0K | $24.3M | ||
| Q2 25 | — | $27.2M | ||
| Q1 25 | $-4.3M | $8.8M | ||
| Q4 24 | $-8.6M | $44.5M | ||
| Q3 24 | $-4.0M | $16.8M | ||
| Q2 24 | — | $17.7M | ||
| Q1 24 | $-7.8M | $12.1M |
| Q4 25 | — | 115.8% | ||
| Q3 25 | 0.1% | 39.4% | ||
| Q2 25 | — | 50.1% | ||
| Q1 25 | -12.1% | 18.4% | ||
| Q4 24 | -26.3% | 93.8% | ||
| Q3 24 | -16.3% | 37.1% | ||
| Q2 24 | — | 40.2% | ||
| Q1 24 | -21.8% | 28.5% |
| Q4 25 | — | 13.3% | ||
| Q3 25 | 5.6% | 3.1% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | 15.5% | 5.7% | ||
| Q4 24 | 7.5% | 14.6% | ||
| Q3 24 | 13.9% | 0.0% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | 17.8% | 0.8% |
| Q4 25 | — | 4.12× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 6.08× | ||
| Q1 25 | — | 0.84× | ||
| Q4 24 | — | 3.88× | ||
| Q3 24 | — | 1.37× | ||
| Q2 24 | — | 1.53× | ||
| Q1 24 | -0.09× | 1.02× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
MPB
Segment breakdown not available.
